Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.36 |
| ▸ | CLK2 | P49760 | 1/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18083391 | 0.98 | MAPK1 (0.41) | MAPK1HTTADORA1ADORA2BKDM4E | |
| SCHEMBL18083349 | 0.95 | MAPK1 (0.43) | MAPK1HTTADORA1KDM4EALDH1A1 | |
| SCHEMBL21347068 | 0.92 | KDM4E (0.44) | MAPK1HTTADORA1ADORA2BKDM4E | |
| SCHEMBL12801009 | 0.92 | ADORA1 (0.41) | MAPK1HTTADORA1ADORA2BKDM4E | |
| SCHEMBL14868035 | 0.89 | MAPK1 (0.53) | MAPK1HTTADORA1ADORA2BKDM4E | |
| SCHEMBL30271371 | 0.89 | MAPK1 (0.41) | MAPK1HTTADORA1MEN1KMT2A | |
| SCHEMBL12800987 | 0.89 | MAPK1 (0.41) | MAPK1HTTADORA1MEN1KMT2A | |
| SCHEMBL25606967 | 0.89 | MAPK1 (0.37) | MAPK1HTTADORA1ADORA2BKDM4E | |
| SCHEMBL17142364 | 0.89 | ADORA3 (0.39) | MAPK1HTTADORA1ADORA2BKDM4E | |
| SCHEMBL15631653 | 0.89 | ADORA2B (0.43) | MAPK1HTTADORA1ADORA2BKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025927-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-01-25 | — | — | US | disclosed |
| US-20230363254-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-09 | — | — | US | disclosed |
| US-20230329089-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230329089-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-12 | — | — | US | disclosed |
| US-11716899-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-01 | — | — | US | disclosed |
| US-10431750-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | UDC IRELAND LIMITED (IE) | 2019-10-01 | — | — | US | disclosed |
| US-20190273211-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | UDC IRELAND LTD (IE) | 2019-09-05 | — | — | US | disclosed |
| US-9806270-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | UDC IRELAND LIMITED (IE) | 2017-10-31 | — | — | US | disclosed |
| US-9806270-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | UDC IRELAND LIMITED (IE) | 2017-10-31 | — | — | US | disclosed |
| US-20160190480-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | BASF SE (DE) | 2016-06-30 | — | — | US | disclosed |
| US-20160190480-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | BASF SE (DE) | 2016-06-30 | — | — | US | disclosed |
| EP-3034508-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2016-06-22 | — | — | EP | disclosed |
| EP-2688889-B1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2016-05-18 | — | — | EP | disclosed |
| WO-2012130709-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-10-04 | — | — | WO | disclosed |
| US-20120241681-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | BASF SE (DE) | 2012-09-27 | — | — | US | disclosed |
| US-20120241681-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | BASF SE (DE) | 2012-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120241681-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | EIF4A1, ITPR2, ITPR1 | MAPK1 1181/4885HTT 2893/4885ADORA1 2120/4885 |
| US-10431750-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | EIF4A1, ITPR2, ITPR1 | MAPK1 1181/4885HTT 2893/4885ADORA1 2120/4885 |
| US-20190273211-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | PAH, NISCH, KCNH1 | MAPK1 1674/4885HTT 298/4885ADORA1 3066/4885 |
| US-20230329089-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NR1H2, OXER1, NR1H3 | MAPK1 830/4885HTT 3729/4885ADORA1 1766/4885 |
| US-20240025927-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, ODC1 | MAPK1 2196/4885HTT 2210/4885ADORA1 4460/4885 |
| US-20160190480-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | PAH, NISCH, KCNH1 | MAPK1 1674/4885HTT 298/4885ADORA1 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.